Evidence map›Paper›PMID 36562442›Full record

ArticleParasite (Paris, France)2022

Experimental evidence that immune trypanolysis using the LiTat 1.3 and LiTat 1.5 variant antigen types is not specific to Trypanosoma brucei gambiense in pigs.

Kadidiata Ilboudo, Robert Eustache Hounyeme, Jacques Kabore, Alain Boulangé, Geoffrey Gimonneau, Ernest Salou, Adrien Gaston Marie Belem, Veerle Lejon, Charlie Franck Alfred Compaoré, Bruno Bucheton and 5 more

Open access · goldAbstract read
In one paragraph

Article in Parasite (Paris, France), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Kadidiata IlboudoUnité de Recherche sur les Maladies à Vecteurs et Biodiversité, Centre International de Recherche-Développement sur l'Élevage en Zone Subhumide, 01 BP 454 Bobo-Dioulasso 01, Burkina Faso - Unité de Formation et de Recherche Sciences et Techniques, Université Nazi Boni, 01 BP 1091 Bobo-Dioulasso, Burkina-Faso.
Robert Eustache HounyemeUnité de Recherche sur les Maladies à Vecteurs et Biodiversité, Centre International de Recherche-Développement sur l'Élevage en Zone Subhumide, 01 BP 454 Bobo-Dioulasso 01, Burkina Faso - Unité de Recherche « Trypanosomoses », Institut Pierre Richet, 01 BP 1500 Bouaké, Côte d'Ivoire.
Jacques KaboreUnité de Recherche sur les Maladies à Vecteurs et Biodiversité, Centre International de Recherche-Développement sur l'Élevage en Zone Subhumide, 01 BP 454 Bobo-Dioulasso 01, Burkina Faso - Unité de Formation et de Recherche Sciences et Techniques, Université Nazi Boni, 01 BP 1091 Bobo-Dioulasso, Burkina-Faso.
Alain BoulangéUnité de Recherche sur les Maladies à Vecteurs et Biodiversité, Centre International de Recherche-Développement sur l'Élevage en Zone Subhumide, 01 BP 454 Bobo-Dioulasso 01, Burkina Faso - Unité de Recherche « Trypanosomoses », Institut Pierre Richet, 01 BP 1500 Bouaké, Côte d'Ivoire - Université de Montpellier, CIRAD, IRD, Intertryp, F-34398 Montpellier, France - CIRAD, UMR INTERTRYP, F-34398 Montpellier, France.
Geoffrey GimonneauUnité de Recherche sur les Maladies à Vecteurs et Biodiversité, Centre International de Recherche-Développement sur l'Élevage en Zone Subhumide, 01 BP 454 Bobo-Dioulasso 01, Burkina Faso - Université de Montpellier, CIRAD, IRD, Intertryp, F-34398 Montpellier, France - Laboratoire National d'Élevage et de Recherches Vétérinaires, Service de Bio-Écologie et Pathologies Parasitaires, BP 2057 Dakar - Hann, Sénégal - CIRAD, UMR INTERTRYP, F-34398 Montpellier, France.
Ernest SalouUnité de Recherche sur les Maladies à Vecteurs et Biodiversité, Centre International de Recherche-Développement sur l'Élevage en Zone Subhumide, 01 BP 454 Bobo-Dioulasso 01, Burkina Faso - Unité de Formation et de Recherche Sciences et Techniques, Université Nazi Boni, 01 BP 1091 Bobo-Dioulasso, Burkina-Faso.
Adrien Gaston Marie BelemInstitut du Développement Rural, Université Nazi Boni, 01 BP 1091 Bobo-Dioulasso 01, Burkina Faso.
Veerle LejonUniversité de Montpellier, CIRAD, IRD, Intertryp, F-34398 Montpellier, France.
Charlie Franck Alfred CompaoréUnité de Recherche sur les Maladies à Vecteurs et Biodiversité, Centre International de Recherche-Développement sur l'Élevage en Zone Subhumide, 01 BP 454 Bobo-Dioulasso 01, Burkina Faso - Unité de Formation et de Recherche Sciences et Techniques, Université Nazi Boni, 01 BP 1091 Bobo-Dioulasso, Burkina-Faso.
Bruno BuchetonUniversité de Montpellier, CIRAD, IRD, Intertryp, F-34398 Montpellier, France.
Mathurin KoffiLaboratoire de Biodiversité et Gestion des Écosystèmes Tropicaux, Unité de Recherche en Génétique et Épidémiologie Moléculaire, UFR Environnement, Université Jean Lorougnon Guédé, BP 150 Daloa, Côte d'Ivoire.
Philippe SolanoUniversité de Montpellier, CIRAD, IRD, Intertryp, F-34398 Montpellier, France.
David BerthierUniversité de Montpellier, CIRAD, IRD, Intertryp, F-34398 Montpellier, France - CIRAD, UMR INTERTRYP, F-34398 Montpellier, France.
Sophie ThevenonUniversité de Montpellier, CIRAD, IRD, Intertryp, F-34398 Montpellier, France - CIRAD, UMR INTERTRYP, F-34398 Montpellier, France.
Vincent JamonneauUnité de Recherche « Trypanosomoses », Institut Pierre Richet, 01 BP 1500 Bouaké, Côte d'Ivoire - Université de Montpellier, CIRAD, IRD, Intertryp, F-34398 Montpellier, France.ORCID 0000-0001-8427-0769
Centre de Coopération Internationale en Recherche Agronomique pour le Développement · FRNazi Boni University · BFCentre international de recherche-développement sur l'elevage en zone subhumide · BFUniversité Jean Lorougnon Guédé · CI

Funding

Bill and Melinda Gates Foundation OPERATIONAL IMPLEMENTATION IN TRANS-BOUNDARY AREAS (INC. PROCUREMENT, SUPPLY CHAIN)
6 · The paper itself

Abstract

In the context of the human African trypanosomiasis elimination process, reliable and accurate diagnostic tools are crucial for exploring the role of a potential animal reservoir of Trypanosoma brucei gambiense. The immune trypanolysis test (TL) using the variant antigen types (VAT) LiTat 1.3 and LiTat 1.5, described as a specific serological method to detect people infected by T. b. gambiense, seems to be a promising tool. However, its specificity was recently questioned during field animal surveys. The present study evaluates the performance of TL during experimental T. b. brucei infection in pigs. Eight infected pigs and four uninfected pigs were followed up with blood and plasma collection. Blood was used for parasitological investigation. TL was performed on the plasma with the LiTat 1.3, LiTat 1.5 and LiTat 1.6 VATs. All control pigs remained negative to parasitological investigation and TL. Trypanosomes were detected in all the infected pigs and the first detection was between 10 and 14 days post infection (dpi). TL results showed that infected pigs developed antibodies against the three VATs. The first antibody detections by TL occurred between 14 and 21 dpi for antibodies directed against LiTat 1.6, 21 and 168 dpi for antibodies directed against LiTat 1.5 and 70, and 182 dpi for antibodies directed against LiTat 1.3. This study highlights for the first time that TL using LiTat 1.3 and LiTat 1.5 VATs is not specific to T. b. gambiense. Development of specific diagnostic tools for the detection of T. b. gambiense infections in animals, especially in pigs, is still needed.

Indexed as

Trypanosoma brucei gambienseTrypanosomiasis, AfricanAnimalsAntibodies, ProtozoanHumansSwineAntibodies, ProtozoanDiagnosisExperimental infectionHuman African trypanosomiasisPigTrypanolysisTrypanosoma brucei

Identifiers

PMID36562442
PMCPMC9879134
OpenAlexW4312194925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.